HCC and angiogenesis: possible targets and future directions

Andrew X. Zhu; Dan G. Duda; Dushyant V. Sahani; Rakesh K. Jain

doi:10.1038/nrclinonc.2011.30

Keywords

MedicineSorafenibHepatocellular carcinomaAngiogenesisSystemic therapyHCCSTumor microenvironmentAntiangiogenic therapyOncologyInternal medicineCancer researchCancer

Affiliated Institutions

Related Publications

Programmed death ligand 1 expression in hepatocellular carcinoma: Relationship With clinical and pathological features

Julien Caldéraro , Benoı̂t Rousseau , Giuliana Amaddeo +9 more

The prognosis of hepatocellular carcinoma (HCC) remains poor, with only one third of patients eligible for curative treatments and very limited survival benefits with the use of...

2016 Hepatology 430 citations

Molecular therapies and precision medicine for hepatocellular carcinoma

Josep M. Llovet , Robert Montal , Daniela Sia +1 more

The global burden of hepatocellular carcinoma (HCC) is increasing and might soon surpass an annual incidence of 1 million cases. Genomic studies have established the land...

2018 Nature Reviews Clinical Oncology 1909 citations

Targeting angiogenesis in hepatocellular carcinoma: focus on VEGF and bevacizumab

Richard S. Finn , Andrew X. Zhu

Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide and one of the few malignancies with an increasing incidence in the USA. While the relationship b...

2009 Expert Review of Anticancer Therapy 111 citations

The Role of Angiogenesis in Hepatocellular Carcinoma

Michael A. Morse , Weijing Sun , Richard D. Kim +4 more

Abstract Hepatocellular carcinoma (HCC) accounts for about 90% of all primary liver cancers and is the second leading cause of cancer-related deaths worldwide. The hypervascular...

2018 Clinical Cancer Research 517 citations

Immunotherapies for hepatocellular carcinoma

Josep M. Llovet , Florian Castet , Mathias Heikenwälder +6 more

Liver cancer, more specifically hepatocellular carcinoma (HCC), is the second leading cause of cancer-related death and its incidence is increasing globally. Around 50% of patie...

2021 Nature Reviews Clinical Oncology 1590 citations

Publication Info

Year: 2011
Type: review
Volume: 8
Issue: 5
Pages: 292-301
Citations: 555
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

HCC and angiogenesis: possible targets and future directions

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

555

OpenAlex

Cite This

APA Style

                            
                                
                                    Andrew X. Zhu, 
                                
                                    Dan G. Duda, 
                                
                                    Dushyant V. Sahani
                                
                                et al.
                            
                            (2011). 
                            HCC and angiogenesis: possible targets and future directions. 
                            Nature Reviews Clinical Oncology
                            , 8
                            (5)
                            , 292-301.
                            https://doi.org/10.1038/nrclinonc.2011.30
                        

Identifiers

DOI: 10.1038/nrclinonc.2011.30